WITTE OWEN N. 4
4 · Allogene Therapeutics, Inc. · Filed Jun 11, 2021
Insider Transaction Report
Form 4
WITTE OWEN N.
Director
Transactions
- Sale
Common Stock
2021-06-09$25.05/sh−9,969$249,723→ 236,182 total - Award
Stock Option (Right to Buy)
2021-06-10+28,015→ 28,015 totalExercise: $25.76Exp: 2031-06-10→ Common Stock (28,015 underlying)
Footnotes (1)
- [F1]The stock option vests in 12 equal monthly installments beginning July 10, 2021.